Literature DB >> 11357179

Dry powders of stable protein formulations from aqueous solutions prepared using supercritical CO(2)-assisted aerosolization.

S P Sellers1, G S Clark, R E Sievers, J F Carpenter.   

Abstract

We report on the use of a new supercritical carbon dioxide-assisted aerosolization coupled with bubble drying technology to prepare stabilized, dry, finely divided powders from aqueous protein formulations. In this study, the feasibility of this new technology was tested using two model proteins, lysozyme and lactate dehydrogenase (LDH). In the absence of excipients, lysozyme was observed to undergo perturbations of secondary structure observed by solid-state infrared spectroscopy. In the presence of sucrose, this unfolding was minimized. Lysozyme did not, however, undergo irreversible loss of activity, as all lysozyme powders generated by supercritical CO(2)-assisted aerosolization (with or without excipients) regained almost complete activity on reconstitution. The more labile LDH suffered irrecoverable loss of activity on reconstituting after supercritical CO(2)-assisted aerosolization and bubble drying in the absence of carbohydrate stabilizers. LDH could be stabilized throughout the nebulization, drying, and rehydration processes with the addition of sucrose, and almost complete preservation of activity was achieved with the further addition of a surface active agent, such as Tween 20, to the aqueous formulation prior to processing. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11357179     DOI: 10.1002/jps.1032

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  16 in total

Review 1.  Stabilization of proteins in dry powder formulations using supercritical fluid technology.

Authors:  Natasa Jovanović; Andréanne Bouchard; Gerard W Hofland; Geert-Jan Witkamp; Daan J A Crommelin; Wim Jiskoot
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

Review 2.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

3.  Supercritical assisted atomization: a novel technology for microparticles preparation of an asthma-controlling drug.

Authors:  Giovanna Della Porta; Carlo De Vittori; Ernesto Reverchon
Journal:  AAPS PharmSciTech       Date:  2005-10-22       Impact factor: 3.246

Review 4.  Particle engineering for pulmonary drug delivery.

Authors:  Albert H L Chow; Henry H Y Tong; Pratibhash Chattopadhyay; Boris Y Shekunov
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

5.  Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques.

Authors:  Wen-Hsuan Lin; Diane E Griffin; Paul A Rota; Mark Papania; Stephen P Cape; David Bennett; Brian Quinn; Robert E Sievers; Charles Shermer; Kenneth Powell; Robert J Adams; Steven Godin; Scott Winston
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

Review 6.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

7.  Formation of stable submicron protein particles by thin film freezing.

Authors:  Joshua D Engstrom; Edwina S Lai; Baltej S Ludher; Bo Chen; Thomas E Milner; Robert O Williams; G Barrie Kitto; Keith P Johnston
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

8.  Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research.

Authors:  Dinesh Kumar Mishra; Vinod Dhote; Punit Bhatnagar; Pradyumna Kumar Mishra
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

9.  Supercritical fluid extraction provides an enhancement to the immune response for orally-delivered hepatitis B surface antigen.

Authors:  Celine A Hayden; Emily M Smith; Debra D Turner; Todd K Keener; Jeffrey C Wong; John H Walker; Ian R Tizard; Rafael Jimenez-Flores; John A Howard
Journal:  Vaccine       Date:  2014-01-28       Impact factor: 3.641

Review 10.  Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability.

Authors:  Tanya Clapp; Paul Siebert; Dexiang Chen; LaToya Jones Braun
Journal:  J Pharm Sci       Date:  2010-08-25       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.